Skip to content
2000
Volume 14, Issue 2
  • ISSN: 1567-2050
  • E-ISSN: 1875-5828

Abstract

In the last decade, several radiolabeled compounds have been developed for the imaging in vivo of amyloid pathology by means of Positron Emission Tomography (PET). Among these, 18F Florbetaben appear to be one of the most reliable for its high affinity for amyloid plaques in brain and its radio-chemical properties that make it usable in common clinical routine. The aim of this review is to provide a general overview of the application in vivo of 18F Florbetaben, describing for first the physiopathological basis of amyloid pathology. Afterwards, the chemical characteristics of this radiolabeled compound will be described, with a particular attention to the synthesis process and the kinetic in vivo. An overview on the imaging protocols and image interpretation will be provided as well and, as a last aspect, the results of the main studies performed in subjects with advanced and early AD will be summarized.

Loading

Article metrics loading...

/content/journals/car/10.2174/1567205013666160620114309
2017-02-01
2025-04-23
Loading full text...

Full text loading...

/content/journals/car/10.2174/1567205013666160620114309
Loading

  • Article Type:
    Research Article
Keyword(s): Alzheimer’s disease; Amyloid; florbetaben; mild cognitive impairment; PET
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test